Pharmacoresistant Convulsions and Visual Hallucinations around Two Weeks after Selegiline Overdose: A Case Report

Abstract

A case of pharmacoresistant convulsions after selegiline overdose is reported. A 50-year-old male having been suffering from bipolar II disorder for 16 years attempted suicide by taking an overdose of 195 mg selegiline with other psychotropics. He developed recurrent pharmacoresistant seizure from 12^th day to 19^th day after selegiline overdose. He also had visual hallucinations and temporary high blood pressure. The authors suspect that the catecholamine-influenced convulsions and visual hallucinations that manifested during the period increased by the MAO-inhibiting action of selegiline which lasts about 2 weeks.

Key words

selegiline - overdose - convulsion

• References

• 1 Fujita Y, Takahashi K, Takei M et al. Detection of levorotatory methamphetamine and levorotatory amphetamine in urine after ingestion of an overdose of selegiline. Yakugaku Zasshi 2008; 128: 1507-1512
• 2 Kumlien E, Lundber PO. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Seizure 2010; 19: 69-73
• 3 Löscher W, Lehmann H. Anticonvulsant efficacy of L-deprenyl (selegiline) during chronic treatment in mice: continuous versus discontinuous administration. Neuropharmacology 1998; 37: 1587-1593
• 4 Weinshenker D, Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol Ther 2002; 94: 213-233